The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 182.50
Bid: 180.00
Ask: 185.00
Change: 0.00 (0.00%)
Spread: 5.00 (2.778%)
Open: 182.50
High: 0.00
Low: 0.00
Prev. Close: 182.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Latest Release of Synectics’ Synergy Software

16 Oct 2023 07:00

RNS Number : 9710P
Synectics PLC
16 October 2023

RNS Reach

16 October 2023

Synectics plc

("Synectics" or the "Company")

Latest Release of Synectics' Synergy Software

Latest update to software platform enhances cyber security and AI capabilities

Synectics plc (AIM: SNX), a leader in advanced security and surveillance systems, announces the release of the latest version of its proprietary software platform, Synergy. This most recent update includes data analysis tools, the integration of further AI and sector-specific capabilities, improved functionality for users and more robust cyber security, further strengthening the system's resilience against cyber threats.

The Synergy platform has long supported the integration of many third-party analytics and AI tools into its single front-end platform for users. Synectics has seamlessly integrated complementary technology from multiple partners, including Microsoft, Nvidia, NEC and many others. The open-architecture nature of the platform provides a bedrock for future upgrades and additional AI tools to be introduced going forward. This enables Synectics to deliver the capabilities required by customers to satisfy both current and future demands, and to allow for a seamless user experience, and cost-effective upgrades, when newer technology from existing or different vendors becomes available.

AI functionality has multiple benefits, including risk detection and data analysis, improved operations and response times and to meet privacy regulations and requirements. For example, AI-powered video search can reduce investigation time from days to minutes.

The Synergy user interface has been simplified and additional functionality introduced, such as the availability of additional formats when generating external reports. The mapping capabilities of the system have also been improved, with CAD maps now included as standard and more premium GIS maps available. Furthermore, this update allows for easier customisation and management of the maps on a customer-by-customer basis.

For more information about Synergy, please visit the Company's website: Synergy Software

Paul Webb, Chief Executive Officer of Synectics, commented:

"This latest release of our Synergy software platform has been developed in conjunction with our customers to respond to their requirements, and the additional security features reflect ongoing development to ensure we maintain cutting-edge solutions against new and emerging threats. We also continue to expand the platform's capability to integrate with third parties to ensure we're able to continue to support leading AI technologies as they are developed and utilised in our markets."

For further information, please contact:

Synectics plc

Paul Webb, Chief Executive Officer

Amanda Larnder, Chief Financial Officer

info@synecticsplc.com

Tel: +44 (0) 114 280 2828

Shore Capital

Tom Griffiths / David Coaten

Tel: +44 (0) 20 7408 4090

Vigo Consulting

Jeremy Garcia / Fiona Hetherington

synectics@vigoconsulting.com

Tel: +44 (0) 20 7390 0230

About Synectics plc

Synectics plc (AIM: SNX) is a leader in advanced security and surveillance systems that help protect people, property, communities, and assets around the world.

The Company's expertise is in providing solutions for specific markets where security and surveillance are critical to operations. These include gaming, oil and gas, public space, transportation, and critical infrastructure.

Synectics has deep industry experience in these markets and works closely with customers to deliver solutions that are tailored to meet their needs. Technical excellence, combined with decades of experience and long-standing customer relationships, provides fundamental differentiation from mainstream suppliers and makes the Company a stand out in its field.

Find out more at www.synecticsplc.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAGPGWUUUPWGWP
Date   Source Headline
4th Feb 20097:00 amRNSInterim Results
16th Jan 200912:06 pmRNSNotification of Results
3rd Sep 20087:00 amRNSPreliminary Results
6th Feb 20087:01 amRNSInterim Results
16th Jan 20087:00 amRNSNotification of Results
6th Dec 20071:09 pmRNSCanc of AIM trading facility
6th Dec 20079:56 amRNSOffer Update
30th Nov 20077:01 amRNSOffer Update
29th Nov 20077:01 amRNSOffer Update
26th Nov 200712:34 pmRNSResult of EGM
23rd Nov 20079:57 amRNSRule 8.1- Synexus
19th Nov 20079:40 amRNSRule 8.1- Synexus
16th Nov 200710:00 amRNSRule 8.1- Synexus
15th Nov 20073:00 pmBUSRule 8.3 - Synexus Clinincal Research Plc
15th Nov 200712:07 pmBUSRule 8.3 - Synexus Clinical Research Plc
15th Nov 20079:16 amRNSRule 8.1- Synexus
14th Nov 20073:21 pmBUSRule 8.3 - Synexus Clinical Research Plc
13th Nov 20073:16 pmBUSRule 8.3 - Synexus Clinical Research Plc
7th Nov 20074:38 pmRNSOffer Document Posted
7th Nov 20077:02 amRNSOffer for Synexus
6th Nov 20079:10 amRNSRule 8.3- Synexus
22nd Oct 200710:46 amRNSHolding(s) in Company
19th Oct 20076:21 pmRNSResponse to price movement
28th Sep 20077:02 amRNSPre Close Statement
5th Sep 20078:33 amRNSBoard Change
5th Sep 20077:01 amRNSPreliminary Results
22nd Aug 20073:17 pmRNSHolding(s) in Company
22nd Aug 200711:19 amRNSAIM RULE 26
15th Jun 20071:26 pmRNSGrant of Options
13th Jun 20077:01 amRNSPreliminary Results
24th May 20074:24 pmRNSNotice of Results
8th Mar 20077:00 amRNSHolding(s) in Company
20th Feb 200712:33 pmRNSGrant of Options
7th Feb 20077:02 amRNSNorth American Contract Wins
7th Feb 20077:02 amRNSInterim Results
6th Feb 200710:14 amRNSDirector/PDMR Shareholding
5th Feb 20077:00 amRNSDirectorate Change
29th Jan 20072:58 pmRNSNotice of Results
26th Jan 20077:01 amRNSTrading Update
28th Dec 20064:36 pmRNSGrant of Options
22nd Dec 20069:37 amRNSTotal Voting Rights & Capital
5th Dec 20067:01 amRNSInterim Results
29th Nov 20063:25 pmRNSDirector/PDMR Shareholding
24th Nov 200611:53 amRNSNotice of Results
24th Oct 20067:01 amRNSAcquisition
4th Oct 20067:00 amRNSTrading Statement
18th Sep 20069:11 amRNSDirectorate Change
13th Jul 20067:01 amRNSIssue of Equity
20th Jun 200610:39 amRNSGrant of Options
14th Jun 20065:06 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.